Jeremy’s Flare characteristics: Creativity and precision.

Jeremy is a trained crystallographer and protein biochemist who is passionate about applying a wide variety of cutting-edge technology to better understand proteins, their 3D structure, and how they bind to small molecules. At Flare, he is excited to collaborate with the rest of the team to bring important new medicines to those who need them.

Jeremy has contributed to a number of oncology-focused drug discovery efforts, including those targeting bromodomains, epigenetic enzymes, transcription factors, and ATPases. As an early member of the Foghorn team, he helped bring the BAF-ATPase inhibitor, FHD-286, to the clinic.

Jeremy enjoys spending time with his wife, Emily, their children, Elle and Max, and their dog, Dexter. If there is any free time left, he enjoys running, cooking, and exploring new restaurants and breweries.